Cefuroxime

Back to search

Molecule Structure

Scientific Name

Cefuroxime

Description of the Drug

Cefuroxime is a cephalosporin indicated for the treatment of a variety of infections including acute bacterial otitis media, several upper respiratory tract infections, skin infections, urinary tract infections, gonorrhea, early Lyme disease, and impetigo.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01112

Brand Name(s)

Not Available

Company Owner(s)

Samson Medical Technologies Llc, Fresenius Kabi Usa Llc, Hospira Inc, Watson Laboratories Inc, Eli Lilly And Co, Pai Holdings Llc Dba Pharmaceutical Associates Inc, Hikma Farmaceutica Portugal Lda, B Braun Medical Inc, Teva Pharmaceuticals Usa, Acs Dobfar Spa

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Bacterial penicillin-binding protein PROTEIN FAMILY INHIBITOR CHEMBL2354204

Unichem Links

SureChEMBL SCHEMBL1821942
Human Metabolome Database HMDB0015244
DrugBank DB01112
PubChem: Thomson Pharma 14758434 16838488
PubChem 5479529
NMRShiftDB 60027800
LINCS LSM-44947
Nikkaji J13.093A
PDBe KOV
BindingDB 50422689
DrugCentral 565
ChemicalBook CB7707485
Guide to Pharmacology 10900
rxnorm CEFUROXIME ZINACEF CEFUROXIME SODIUM
PubChem: Drugs of the Future 12015285
KEGG Ligand C06894
ChEBI 3515
ZINC ZINC000003871978